A team led by researchers at Toronto's Mount Sinai Hospital has completed a proteomic analysis of the scaffold protein Shc1 and its role in regulating EGF signaling.

The study, published this week in Nature, offers insights into the processes and protein interactions through which Shc1 modulates EGF network activity. It also provides a demonstration of targeted proteomics' potential as a tool for unraveling complex cellular processes.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.